[Form 4] Microvision Inc Insider Trading Activity

Rhea-AI Filing Summary

Jeffrey A. Herbst, a director of MicroVision, Inc. (MVIS), received 22,007 shares of common stock on 09/02/2025 upon vesting of restricted stock units (RSUs). The RSUs converted on a one-for-one basis into common shares at no cash payment, increasing His beneficial ownership to 186,713 shares following the transaction. The filing corrects an earlier grant reporting error: the original Form 4 filed 06/06/2025 misstated the total RSUs granted; the correct total used for vesting calculations is 88,028 RSUs.

This Form 4 reports a routine equity compensation vesting event for a director and does not disclose any sale or cash proceeds. The transaction was reported on 09/03/2025 by an attorney-in-fact signing for the reporting person.

Positive

• Director received 22,007 vested RSUs converted to common stock
• Beneficial ownership increased to 186,713 shares
• Filing corrected an earlier reporting error on total RSUs granted (correct amount 88,028)

Negative

• None.

Insights

Securities Analyst

TL;DR: Director received vested RSUs converting to 22,007 shares, raising beneficial ownership to 186,713—routine compensation, no sales.

The filing documents a standard director compensation event: RSUs granted earlier converted into shares without cash consideration, and the reporting corrects a prior grant quantity error. For investors, such vesting signals management/director alignment with shareholders but is not a liquidity event because no shares were sold. The corrected grant total (88,028 RSUs) versus the previously reported figure should be noted for accuracy in insider holdings tracking.

Corporate Governance Expert

TL;DR: Administrative correction plus routine issuance of vested RSUs; governance implications are minimal and procedural.

The Form 4 clarifies the number of RSUs originally granted and records the scheduled vesting that produced 22,007 shares on 09/02/2025. This is consistent with common director equity compensation practices and the vesting schedule described for the grant dated 06/06/2025. No change in control, director departure, or share disposals are reported, so this filing appears procedural rather than material to corporate governance dynamics.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Herbst Jeffrey A

(Last) (First) (Middle)

18390 NE 68TH STREET

(Street)

REDMOND WA 98052

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MICROVISION, INC. [ MVIS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/02/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/02/2025		M		22,007	A	$0.00(1)	186,713	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	$0.00(2)	09/02/2025		M			22,007	09/02/2025(3)	09/02/2025(3)	Common stock	22,007	$0.00	0	D

Explanation of Responses:

1. Vested restricted stock units, or RSUs, were distributed to the Reporting Person, without payment, in shares of common stock on a unit-for-share basis.

2. At vesting, RSUs convert into shares of common stock on a unit-for-share basis, without payment.

3. RSUs granted 06/06/2025 are scheduled to vest in four equal quarterly installments until fully vested on the earlier of the first anniversary of the grant date or the day prior to the Issuer's 2026 Annual Meeting of Stockholders, provided that the reporting person continues to serve as a director through each vesting date.The Form 4 filed on 06/06/2025 incorrectly reported the total RSUs granted on 06/05/2025 as 87,462 RSUs instead of the correct amount of 88,208 RSUs. The vesting reported herein was calculated based on the correct amount of 88,028 RSUs.

	/s/ Drew G. Markham, attorney-in-fact for Jeffrey A. Herbst	09/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did MVIS director Jeffrey A. Herbst receive on 09/02/2025?

He received 22,007 shares of MicroVision common stock upon vesting of RSUs, issued on a unit-for-share basis with $0.00 paid.

How many shares does Jeffrey A. Herbst beneficially own after the transaction?

Following the reported transaction his beneficial ownership is 186,713 shares.

Was there a cash purchase or sale reported in this Form 4 for MVIS?

No. The report shows an RSU distribution converting to shares at $0.00; there were no sales or cash proceeds disclosed.

Did the Form 4 correct any prior errors?

Yes. The filing states the Form 4 filed 06/06/2025 incorrectly reported total RSUs; the correct total used is 88,028 RSUs for vesting calculations.